These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15847697)

  • 1. Comparison of amplification enzymes for Hepatitis C Virus quasispecies analysis.
    Polyak SJ; Sullivan DG; Austin MA; Dai JY; Shuhart MC; Lindsay KL; Bonkovsky HL; Di Bisceglie AM; Lee WM; Morishima C; Gretch DR;
    Virol J; 2005 Apr; 2():41. PubMed ID: 15847697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inferred hepatitis C virus quasispecies diversity is influenced by choice of DNA polymerase in reverse transcriptase-polymerase chain reactions.
    Mullan B; Kenny-Walsh E; Collins JK; Shanahan F; Fanning LJ
    Anal Biochem; 2001 Feb; 289(2):137-46. PubMed ID: 11161307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy.
    Fan X; Mao Q; Zhou D; Lu Y; Xing J; Xu Y; Ray SC; Di Bisceglie AM
    Hepatology; 2009 Dec; 50(6):1765-72. PubMed ID: 19937690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variability.
    Shuhart MC; Sullivan DG; Bekele K; Harrington RD; Kitahata MM; Mathisen TL; Thomassen LV; Emerson SS; Gretch DR
    J Infect Dis; 2006 May; 193(9):1211-8. PubMed ID: 16586356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypervariable region 1 of hepatitis C virus genome and response to interferon therapy.
    Grahovac B; Bingulac-Popović J; Vucelić B; Hrstić I; Ostojić R; Drazić V; Balija M; Grgicević D
    Clin Chem Lab Med; 2000 Sep; 38(9):905-10. PubMed ID: 11097348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexity and catalytic efficiency of hepatitis C virus (HCV) NS3 and NS4A protease quasispecies influence responsiveness to treatment with pegylated interferon plus ribavirin in HCV/HIV-coinfected patients.
    Aparicio E; Franco S; Parera M; Andrés C; Tural C; Clotet B; Martínez MA
    J Virol; 2011 Jun; 85(12):5961-9. PubMed ID: 21471227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
    Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
    J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.
    Morishima C; Polyak SJ; Ray R; Doherty MC; Di Bisceglie AM; Malet PF; Bonkovsky HL; Sullivan DG; Gretch DR; Rothman AL; Koziel MJ; Lindsay KL;
    J Infect Dis; 2006 Apr; 193(7):931-40. PubMed ID: 16518754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C.
    Gerotto M; Sullivan DG; Polyak SJ; Chemello L; Cavalletto L; Pontisso P; Alberti A; Gretch DR
    J Virol; 1999 Sep; 73(9):7241-7. PubMed ID: 10438811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens.
    Sherman KE; Rouster SD; Stanford S; Blackard JT; Shire N; Koziel M; Peters M; Chung RT;
    J Infect Dis; 2010 Mar; 201(5):712-9. PubMed ID: 20105080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate representation of the hepatitis C virus quasispecies in 5.2-kilobase amplicons.
    Liu Z; Netski DM; Mao Q; Laeyendecker O; Ticehurst JR; Wang XH; Thomas DL; Ray SC
    J Clin Microbiol; 2004 Sep; 42(9):4223-9. PubMed ID: 15365015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus NS3/4A quasispecies diversity in acute hepatitis C infection in HIV-1 co-infected patients.
    Nevot M; Boesecke C; Parera M; Andrés C; Franco S; Revollo B; Ingiliz P; Tural C; Clotet B; Rockstroh JK; Martinez MA;
    J Viral Hepat; 2014 Jun; 21(6):e19-28. PubMed ID: 24674023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of increased CD4 cell counts on the genetic variability of hepatitis C virus in patients co-infected with human immunodeficiency virus I.
    Wang XP; Goodwin L; Kahn P; Gawel C; Cunha CB; Laser B; Sahn B; Kaplan MH
    J Biomol Tech; 2006 Jul; 17(3):228-39. PubMed ID: 16870714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
    Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE;
    Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy.
    Solmone M; Girardi E; Lalle E; Abbate I; D'Arminio Monforte A; Cozzi-Lepri A; Alessandrini A; Piscopo R; Ebo F; Cosco L; Antonucci G; Ippolito G; Capobianchi MR; ;
    Antivir Ther; 2006; 11(1):87-94. PubMed ID: 16518964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wide range of quasispecies diversity during primary hepatitis C virus infection.
    Herring BL; Tsui R; Peddada L; Busch M; Delwart EL
    J Virol; 2005 Apr; 79(7):4340-6. PubMed ID: 15767434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion.
    Laskus T; Wilkinson J; Gallegos-Orozco JF; Radkowski M; Adair DM; Nowicki M; Operskalski E; Buskell Z; Seeff LB; Vargas H; Rakela J
    Gastroenterology; 2004 Sep; 127(3):764-76. PubMed ID: 15362033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: correlation with nucleotide sequencing.
    Wilson JJ; Polyak SJ; Day TD; Gretch DR
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1763-71. PubMed ID: 9049381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of highly active antiretroviral therapy on hepatitis C virus protease quasispecies diversity in HIV co-infected patients.
    Winters MA; Chary A; Eison R; Asmuth D; Holodniy M
    J Med Virol; 2010 May; 82(5):791-8. PubMed ID: 20336744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients.
    Babik JM; Holodniy M
    J Virol; 2003 Feb; 77(3):1940-50. PubMed ID: 12525628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.